牛熊異動 | 李寧拉升,衍生品升幅超300%
李寧(02331.HK)高開逾6%,截至目前升幅超10%,相關衍生品李寧摩通零八購A(28721.HK)升幅超300%。
據報導,發佈公告,上半年權益持有人應占利潤6.83億元,同比下滑14%。公告稱,上半年,毛利率由49.7%下滑至49.5%。集團在促銷零售環境下增加折扣。此外,存貨撥備因存貨總值增加而增加。此負面影響部分由新品追加吊牌價增加所抵銷。EBITDA為14.07億元,同比增長4.1%。由於銷售量下跌,零售流水(包括線上及線下)出現10%-20%下跌。截至9時27分,升6.53%,報價31港元,成交額3756.37萬。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.